AI assistant
MACH7 TECHNOLOGIES LIMITED — Share Issue/Capital Change 2017
Jan 17, 2017
65285_rns_2017-01-17_44a72aff-992e-4500-822a-0b1222a9279d.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
18 January 2017
==> picture [599 x 88] intentionally omitted <==
ASX Announcement
Post-Consolidation Capital Structure
Melbourne, Australia; 18 January 2017: Further to Mach7 Technologies Limited’s (the Company ) announcement dated 16 January 2017 about its recent consolidation, the Company sets out below details on its post-consolidation capital structure and terms of its consolidated options and performance shares on issue.
The Company confirms that the record date for the consolidation was 12 January 2017 .
| Fully paid ordinary shares | |
|---|---|
| No escrow restrictions | 67,739,871 |
| Escrowed until 1 June 2017 | 339,850 |
| Escrowed until 1 July 2017 | 57,690 |
| Escrowed until 18 February 2017 | 5,874,817 |
| Escrowed until 8 April 2017 | 44,193,300 |
| TOTAL ORDINARY SHARES ON ISSUE | 118,205,528 |
| Options to acquire ordinary shares | |
| Options exercisable at$0.50, expiring 6 February 2017 | 4,289,245 |
| No escrow restrictions |
2,995,260 |
| Escrowed until18 February2017 |
1,293,985 |
| Options exercisable at$1.00, vesting on 8 April 2017 and expiring 8 April 2020 | 100,000 |
| Options exercisable at$1.00, vesting on 8 April 2018 and expiring 8 April 2021 | 475,000 |
| Options exercisable at$1.00, vesting on 9 Dec 2018 and expiring 9 Dec 2021 | 125,000 |
| TOTAL OPTIONS ON ISSUE | 4,989,245 |
| Performance shares | |
|---|---|
| No escrow restrictions | 1,143,261 |
| Class A Performance Shares | 571,632 |
| Class B Performance Shares | 190,543 |
| Class C Performance Shares | 190,543 |
| Class D Performance Shares | 190,543 |
| Escrowed until 8 April 2017 | 28,856,738 |
| Class A Performance Shares | 14,428,370 |
| ClassB Performance Shares | 4,809,456 |
| Class C Performance Shares | 4,809,456 |
| Class D Performance Shares | 4,809,456 |
| TOTAL PERFORMANCE SHARES ON ISSUE | 29,999,999 |
==> picture [612 x 123] intentionally omitted <==
ASX Announcement
18 January 2017
==> picture [599 x 88] intentionally omitted <==
Terms of Performance Shares (post- consolidation)
Class A Performance Shares
Subject to vesting milestone that the annual reported gross revenue attributable to the Mach7 Group is equal to or exceeds US$6,000,000 for calendar year ( CY ) 2016 and the volume weighted average price ( VWAP ) of the Company’s ordinary shares for any 20-day period during CY16 is equal to or exceeds $2.00 (on a post-consolidation basis).
Where the Class A Performance Shares have not converted into ordinary shares during CY16, that the annual reported gross revenue attributable to the Mach7 Group is equal to or exceeds US$6,600,000 for CY17 and the VWAP of the Company’s ordinary shares for any 20-day period during CY17 is equal to or exceeds $2.00 (on a post-consolidation basis).
Class B Performance Shares
Subject to vesting milestone that the annual reported gross revenue attributable to the Mach7 Group is equal to or exceeds US$6,000,000 for CY16 and the VWAP of the Company’s ordinary shares for any 20day period during CY16 is equal to or exceeds $2.50 (on a post-consolidation basis).
Where the Class B Performance Shares have not converted into ordinary shares during CY16, that the annual reported gross revenue that is attributable to the Mach7 Group is equal to or exceeds US$6,600,000 for CY17 and the VWAP of the Company’s ordinary shares for any 20-day period during CY17 is equal to or exceeds $2.50 (on a post-consolidation basis).
Class C Performance Shares
Subject to vesting milestone that the annual reported gross revenue attributable to the Mach7 Group is equal to or exceeds US$12,000,000 for CY16.
Class D Performance Shares
Subject to vesting milestone that the annual reported gross revenue attributable to the Mach7 Group is equal to or exceeds US$20,000,000 for CY17.
- ENDS
Contacts:
Jenni Pilcher Alyn Tai CEO Australia, CFO Company Secretary +61 3 9646 2222 (Australia) +61 3 9286 7500 (Australia) [email protected] [email protected]
==> picture [612 x 123] intentionally omitted <==
18 January 2017
==> picture [599 x 88] intentionally omitted <==
ASX Announcement
About Mach7 Technologies:
Mach7 Technologies (ASX:M7T) develops innovative enterprise imaging IT solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s awardwinning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimised vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com
Mach7’s wholly-owned subsidiary, 3D Medical Pty Ltd, provides medical specific 3D printing and is an exclusive distributor of various synergistic technologies including holographic projection. 3D Medical’s innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes. Visit www.3dmedical.com.au
==> picture [612 x 123] intentionally omitted <==